Postpartum factor VIII inhibitors. Report of two cases with special reference to the efficacy of various treatments.
Two cases of postpartum inhibitors to F VIII are described. One patient had a severe bleeding tendency (iliopsoas bleeding, forearm bleeding). The maximum inhibitor titer was 800 BU/ml in case 1 and 120 BU/ml in case 2. Bleeding was controlled by treatment with human and porcine factor VIII concentrate and with activated prothrombin complex concentrate (FEIBA, Immuno AG, Vienna, Austria) in case 1, while no replacement therapy was given in case 2. Prednisone (given in both cases) and high-dose immunoglobulin (given in case 2) was without effect. Cyclophosphamide (100 mg per day), combined with small doses of prednisone led to complete disappearance of the inhibitor and normalization of factor VIII in case 1. In the other patient who refused treatment with cyclophosphamide the inhibitor titer remained high over a period of 13 months.
Hauser
I
I
Abteilung Hämatologie/Hämostaseologie, Universität Wien.
Gisslinger
H
H
Locker
G
G
Elbl
W
W
Kyrle
P A
PA
Pabinger
I
I
Lechner
K
K
D000328:Adult; D001780:Blood Coagulation Tests; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005169:Factor VIII / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000627:therapeutic use; D005260:Female; D006474:Hemorrhagic Disorders / Q000097:blood / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D006473:Postpartum Hemorrhage / Q000097:blood / Q000188:drug therapy; D011239:Prednisolone / Q000008:administration & dosage; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood* / Q000188:drug therapy; D011644:Puerperal Disorders / Q000097:blood* / Q000188:drug therapy
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D005169:Factor VIII; D011239:Prednisolone